Related Experiment Video

Updated: Jul 9, 2026

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice
09:43

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice

Published on: June 8, 2022

The outcome of lupus nephritis in Jamaican patients

Winston Williams1, Lincoln A Sargeant, Monica Smikle

  • 1Department of Medicine, University of the West Indies, Mona Campus, Kingston, Jamaica. wdw@cwjamaica.com

The American Journal of the Medical Sciences
|December 20, 2007
PubMed

Insights

This study on black Jamaican patients with lupus nephritis found no significant difference in outcomes like end-stage renal disease or death between different lupus nephritis classes. Lupus nephritis prognosis appears similar across these groups.

Area of Science:

  • Nephrology
  • Rheumatology
  • Immunology

Background:

  • Systemic lupus erythematosus (SLE) with nephritis is a serious condition affecting kidney function.
  • Understanding the prognosis of lupus nephritis in specific populations, such as black Jamaicans, is crucial for patient care.
  • Lupus nephritis is classified into different classes based on kidney biopsy findings, influencing treatment and outcomes.

Purpose of the Study:

  • To investigate the clinical outcomes and prognosis of black Jamaican patients with lupus nephritis.
  • To compare outcomes between different classes of lupus nephritis, specifically grouping classes III/IV versus classes II/V and interstitial nephritis.
  • To assess the rates of end-stage renal disease (ESRD) or death in these patient groups.

Main Methods:

  • A cohort of 66 black Jamaican patients with lupus nephritis was analyzed.
  • Patients were classified based on kidney biopsy findings (classes I-VI) and interstitial nephritis.
  • Two groups were formed: Group 1 (classes III and IV) and Group 2 (classes II, V, and interstitial nephritis).
  • Clinical data including hemoglobin, serum creatinine, hypertension, and chronicity scores were compared.
  • Event-free survival rates for ESRD or death, and for death alone, were calculated at 1, 2, and 5 years.

Main Results:

  • Group 1 (classes III/IV) showed significantly lower hemoglobin, higher serum creatinine, and higher prevalence of hypertension and chronicity scores compared to Group 2.
  • Despite these differences, there was no statistically significant difference in the percentage of patients event-free for ESRD or death between Group 1 (69.0% at 5 years) and Group 2 (57.4% at 5 years).
  • Similarly, survival free from death alone showed no significant difference between the groups at 5 years (Group 1: 86.7% vs. Group 2: 67.3%).
  • Overall, 16 patients (25.4%) developed ESRD or died during the follow-up period.

Conclusions:

  • In this cohort of black Jamaican patients with lupus nephritis, the histological class of nephritis did not significantly impact the long-term prognosis regarding end-stage renal disease or death.
  • Clinical parameters like hemoglobin and serum creatinine differed between groups, but did not translate into divergent survival outcomes.
  • Further research may be needed to understand the factors influencing lupus nephritis outcomes in this specific population.

Related Concept Videos

Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Nephrotic Syndrome III : Nursing Management01:24

Nephrotic Syndrome III : Nursing Management

Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...